Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes
Authors:
- Frederick A. SpencerFSFrederick A. Spencer
- Michael GibsonMGMichael Gibson
- Janet E. RushJRJanet E. Rush
- Gerard SanderinkGSGerard Sanderink
- Sabina A. MurphySMSabina A. Murphy
- Steven P. BallSBSteven P. Ball
- Elliott M. AntmanEAElliott M. Antman
- 1 May 2002
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 143 (5) , 753-759
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Serum creatinine levels in the US population: Third National Health and Nutrition Examination SurveyAmerican Journal of Kidney Diseases, 1998
- Dose-Ranging Trial of Enoxaparin for Unstable Angina: Results of TIMI 11A 11A list of the participating investigators and clinical centers for the TIMI 11A trial appears in the Appendix A.JACC, 1997
- Low-molecular-weight heparin during instability in coronary artery diseaseThe Lancet, 1996
- Coronary artery bypass grafting in patients with dialysis-dependent renal failureThe Annals of Thoracic Surgery, 1994
- Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.Circulation, 1994
- Low molecular weight heparinBlood, 1992
- Coronary Artery Bypass Surgery in Patients on Chronic HemodialysisAnnals of Internal Medicine, 1989
- Practical Considerations on the Measurement of Low Molecular Weight Heparin Anti-Xa ActivitySeminars in Thrombosis and Hemostasis, 1985
- Assay of heparin in plasma using a chromogenic substrate for activated factor XThrombosis Research, 1976
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976